疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

  p2 J+ B! b5 ^

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

5 s& y& l" J4 h& Uhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
% O' A! k, _' t: g  K# G3 The vaccine industry 33
4 Vaccine manufacturing 44
0 Z) d* a1 {4 h7 U+ S5 Evolution of adjuvants across the centuries 58
  G1 I% i4 d, b5 h6 Vaccine additives and manufacturing residuals in the United States:
" U6 ]$ ^( K; o" d0 M% y6 ^/ U* Mlicensed vaccines 71
7 Passive immunization 80
& b) z) i6 x( I3 ~8 General immunization practices 88
: f! K' l; w, D, p* C' F- MSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
: x4 t6 x5 B2 }  W* y10 Anthrax vaccines 127
11 Cholera vaccines 141
8 I+ I4 W5 f) r' l& W12 Diphtheria toxoid 153
, f; _. y& P7 _1 S! M3 ~13 Haemophilus influenzae vaccines 167
3 d* Q3 d/ ], K7 y( @14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
# ?4 Z, D" C5 i! \! b( V17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
4 r7 U( b+ ]( \1 m, V+ @  M6 Y0 u& t19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
, N1 P2 H9 @6 g+ V25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
: M  C4 T( A% X2 y. m0 g6 E: d26 Pneumococcal polysaccharide vaccines 542
6 c$ ]2 x; y4 y0 f( G6 `27 Poliovirus vaccine-inactivated . 573
' H& f% O5 r4 O; K/ l/ y( v1 d" x28 Poliovirus vaccine-live 598
3 I0 t, l/ q% `( a% h29 Rabies vaccines .646
* J1 {7 V4 ?) S, v30 Rotavirus vaccines . 669
- ^7 B1 e% ^( b# N+ x2 a31 Rubella vaccine 688
5 Y7 h. _4 G( S+ a: r3 X* J32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
" L" v) E3 c0 B1 i: H43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
: O4 X, p) n5 l+ Y5 T* Q1 E5 C7 J45 Diarrhea caused by bacteria 1052
" v: f' K& o* b* V1 i( a46 Ebola vaccine 1060
! u, s* D' Y! h2 o  Z! G47 Epstein-Barr virus vaccines 1068
" a$ p: P  V6 a5 P2 M48 Hepatitis C vaccines 1074
; G( F5 f+ U8 n4 H" P2 F49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
! R4 w) K8 a/ Z+ K9 J52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
2 r6 {$ s9 w! ~  z55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
0 H3 |5 T+ L! i$ v56 Parasitic disease vaccines 1154
9 Z' |4 s% u0 ?# c57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
& F+ `+ }, [$ }. b8 `/ q60 Technologies for making new vaccines 1182
. y+ A3 v  \* l1 D8 b2 y" Q61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
5 g+ s2 }- S# w  h% |  f: \7 X63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
: g3 i2 x, h, L: V+ Y* h66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
  Q+ u) t9 _6 o( Y# y$ K68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
, w; P6 j2 ~; c- K$ w. d70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
3 H' U9 o* _2 Q/ B74 Regulation of vaccines in Europe 1447
$ G* ?: K+ [% w7 W75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508



- l" D6 `1 X( c* x& g1 U  u$ ^6 `

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

' O" y: n# L7 x  h3 E3 B$ X. v) R! d) nVaccines, 6th Edition
+ ^) [; ?5 {- p- D7 h
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
. p3 T% s# f/ Y6 O3 }
http://yun.baidu.com/share/link? ... 1&uk=3810996606

SECTION 1: General aspects of vaccination
% c! p/ B" T0 l- }5 b% W7 ^1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
( e: w/ q7 k# Q& ~5 @3 l; K4 Vaccine manufacturing 44
8 ^# f1 F  v* m1 p5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
$ b$ X6 \' D8 {$ `0 M7 o6 i. k7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
8 z7 I- \5 r2 A/ x9 _2 e* I9 Adenovirus vaccines 113
10 Anthrax vaccines 127
7 B7 L6 ]+ p! o# @" J" N11 Cholera vaccines 141
) Z) w: t0 g- l0 l. Y1 j9 b$ k12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
& m7 f3 i8 y  ]! i14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
( A; {/ z" J' ^  G" E16 Human papillomavirus vaccines 235
8 q7 B/ }& Q1 m- @) x9 t8 @17 Inactivated influenza vaccines 257
$ V- l3 r9 ^1 K) L8 T18 Influenza vaccine-live 294
' d1 a! }4 _8 e& v/ F19 Japanese encephalitis vaccines 312
# Y  @5 z) z) K+ N  A( z) V20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
7 ?" y1 \" j* u, P, v25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
  B6 _, N, F- S$ u  O27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
2 u/ P+ j4 D& u, ]; N* d29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
6 R+ h% A3 e9 K5 P! G32 Smallpox and vaccinia 718
3 x' n6 W. g; m33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
) c) H4 I( R1 ]3 J* u! S: ^, C35 Tuberculosis vaccines 789
: ], R+ o7 L( ~8 B) f36 Typhoid fever vaccines 812
37 Varicella vaccine 837
8 S& P5 v2 j+ F- C38 Yellow fever vaccine 870
7 A, c- U; a# H$ Y* @8 w39 Zoster vaccine 969
40 Combination vaccines 981
4 `& a- k2 E& {: ^+ E8 ~SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
9 Z/ ?( u" ?3 t/ l  }3 g7 g44 Dengue vaccines 1042
. {! \; w: \/ l8 }& w  d! @45 Diarrhea caused by bacteria 1052
3 a  b: v7 X) A/ S' F8 a  v46 Ebola vaccine 1060
- O0 c% p  d, d3 Q# ]# u47 Epstein-Barr virus vaccines 1068
5 `/ s1 b6 f" m* _( _6 W48 Hepatitis C vaccines 1074
  ^3 ]& R1 I. D0 P49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
5 F& i* }7 X" A  ~51 Human immunodeficiency virus vaccines 1097
# M4 |' d1 P. O. F& X52 Lyme disease vaccines 1122
: E3 y9 V$ @$ D' v( ]53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
4 Q4 V( t" v2 O3 z0 q58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
3 N0 W/ M3 x, H$ v2 W. b60 Technologies for making new vaccines 1182
/ L% D7 {* J5 A. m3 ^61 Alternative vaccine delivery methods 1200
; U' i( X0 S. \# ]! j62 The development of gene-based vectors for immunization 1232
9 b0 \* d1 }; l0 n6 A* iSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
9 C5 S9 ^( J) ?: T! _) U64 Vaccination of human immunodeficiency virus-infected persons 1257
, \  j* ^& _' H65 Vaccines for international travel 1270
/ T9 K/ ?1 s+ U9 R; s- @66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
3 f6 f  B2 `" i! ^! Z70 Immunization in developing countries 1369
71 Community immunity 1395
' _0 |1 N! J7 E, O72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
* I8 c! B% O- k6 E; t- d/ s4 d77 Legal issues . 1481
1 D1 }* O0 T8 ~; D78 Ethics 1508
6 y  n2 ]' g, N9 z
( [7 S- g+ y+ k

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
3 \7 v- N. [6 K4 g+ v$ h9 uLanguage: English
4 f: O: s: l- }1 a! YISBN-10: 1455700908
  M/ j" y% L4 a7 u' m1 OSize: 52.3mb (original pdf)

2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

) e: D7 T+ O0 |$ F/ K$ S2 oGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
! ^( K* E# _6 d: p% `, \Clearly visualize concepts and objective data through an abundance of tables and figures.
6 Q2 f# _, o/ p" ^2 k' e+ e* |# R3 CPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
3 x/ \7 H3 z; q8 U. rMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
- d, Z7 z! u) TStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
+ b9 Q7 o1 y! t, K
2 R5 ]" K8 H, ~, K1 _9 x* b  cDownload link: http://pan.baidu.com/s/1i5NxwLR
' L0 Z2 z0 ]' `Code for downloading: dv96
' N  q, R- h: m! Y' h5 z3 r6 n